Wound Care Market by Product (Dressings (Foam, Hydrocolloid, Collagen), Devices (NPWT, Debridement), Biological Skin Substitutes, Sutures, Staplers), Wounds (Chronic, Acute)), End User (Hospitals, Clinics, Home Care), and Region -Global Forecast to 2030

1 INTRODUCTION 40 1.1 STUDY OBJECTIVES 40 1.2 MARKET DEFINITION 41 1.3 STUDY SCOPE 41 1.3.1 MARKET SEGMENTATION AND REGIONAL SCOPE 41 1.3.2 INCLUSIONS AND EXCLUSIONS 42 1.4 YEARS CONSIDERED 44 1.5 CURRENCY CONSIDERED 44 1.6 STAKEHOLDERS 44 1.7 SUMMARY OF CHANGES 45 2 RESEARCH METHODOLOGY 46 2.1 RESEARCH DATA 46 2.1.1 SECONDARY DATA 47 2.1.1.1 Key data from secondary sources 47 2.1.2 PRIMARY DATA 48 2.1.2.1 Primary sources 48 2.1.2.2 Key industry insights 49 2.1.2.3 Key data from primary sources 49 2.1.2.4 Breakdown of primary interviews 51 2.2 MARKET SIZE ESTIMATION 51 2.2.1 BOTTOM-UP APPROACH 52 2.2.1.1 Approach 1: Company revenue estimation approach 52 2.2.1.2 Approach 2: Presentations of companies 52 2.2.1.3 Approach 3: Primary interviews 52 2.2.1.4 Growth forecast 53 2.2.1.5 CAGR projections 53 2.2.2 TOP-DOWN APPROACH 53 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 54 2.4 RESEARCH ASSUMPTIONS 55 2.4.1 STUDY-RELATED ASSUMPTIONS 55 2.4.2 ASSUMPTIONS, BY PARAMETER 56 2.4.3 GROWTH RATE ASSUMPTIONS 56 2.5 RESEARCH LIMITATIONS 56 2.6 RISK ASSESSMENT 57 3 EXECUTIVE SUMMARY 58   4 PREMIUM INSIGHTS 62 4.1 WOUND CARE MARKET OVERVIEW 62 4.2 ASIA PACIFIC: WOUND CARE MARKET SHARE, BY END USER AND COUNTRY 63 4.3 WOUND CARE MARKET, BY KEY COUNTRY 64 4.4 WOUND CARE MARKET: REGIONAL MIX, 2023–2030 64 5 MARKET OVERVIEW 65 5.1 INTRODUCTION 65 5.2 MARKET DYNAMICS 65 5.2.1 DRIVERS 66 5.2.1.1 Growing geriatric population 66 5.2.1.2 Rise in cases of traumatic injuries 67 5.2.1.3 Growing prevalence of chronic diseases 67 5.2.1.4 Rising incidence of burn injuries 68 5.2.1.5 Rising use of regenerative medicines for wound management 69 5.2.1.6 Government initiatives and reimbursement policies 69 5.2.2 RESTRAINTS 70 5.2.2.1 High cost of advanced wound care products 70 5.2.2.2 Risks associated with advanced wound care products 71 5.2.2.3 Antimicrobial resistance challenges 71 5.2.3 OPPORTUNITIES 72 5.2.3.1 Growth opportunities in emerging economies 72 5.2.3.2 Technological advancements in wound care 72 5.2.3.3 Home care-optimized solutions 73 5.2.4 CHALLENGES 73 5.2.4.1 Lack of trained healthcare professionals 73 5.2.4.2 Limited access to wound care solutions in underdeveloped regions 74 5.2.4.3 Data security and privacy concerns 74 5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS 74 5.4 PRICING ANALYSIS 75 5.4.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 75 5.4.2 AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS FOR KEY WOUND TYPES, BY KEY PLAYER 76 5.4.3 AVERAGE SELLING PRICE TREND, BY REGION 77 5.5 VALUE CHAIN ANALYSIS 77 5.6 SUPPLY CHAIN ANALYSIS 79 5.7 ECOSYSTEM ANALYSIS 80 5.8 INVESTMENT & FUNDING SCENARIO 81 5.9 TECHNOLOGY ANALYSIS 82 5.9.1 KEY TECHNOLOGIES 82 5.9.1.1 Negative pressure wound therapy 82 5.9.2 COMPLEMENTARY TECHNOLOGIES 82 5.9.2.1 Micropore particle technology 82 5.9.3 ADJACENT TECHNOLOGIES 83 5.9.3.1 Telemedicine and Mobile Health (MHealth) 83 5.10 PATENT ANALYSIS 83 5.11 TRADE ANALYSIS 85 5.11.1 IMPORT SCENARIO 85 5.11.2 EXPORT SCENARIO 86 5.12 KEY CONFERENCES AND EVENTS, 2025–2026 86 5.13 CASE STUDY ANALYSIS 87 5.13.1 CASE STUDY 1: ADOPTION OF ADVANCED WOUND CARE MEASURES FOR COMPLEX WOUND HEALING 87 5.13.2 CASE STUDY 2: EVALUATION OF NEW HYDROCOLL HYDROCOLLOID DRESSING IN WOUND CARE 88 5.13.3 CASE STUDY 3: SUPPORTED SELF-MANAGEMENT OF HARD-TO-HEAL PRESSURE ULCERS USING SIMPLE 3-STEP FRAMEWORK DEVELOPED BY COLOPLAST 89 5.14 REGULATORY LANDSCAPE 89 5.14.1 REGULATORY ANALYSIS 89 5.14.1.1 North America 89 5.14.1.1.1 US 89 5.14.1.1.2 Canada 89 5.14.1.2 Europe 90 5.14.1.2.1 Germany 90 5.14.1.2.2 UK 90 5.14.1.2.3 France 90 5.14.1.3 Asia Pacific 91 5.14.1.3.1 China 91 5.14.1.3.2 Japan 91 5.14.1.3.3 India 91 5.14.1.4 Latin America 92 5.14.1.5 Middle East 92 5.14.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 5.14.2.1 North America 92 5.14.2.2 Europe 93 5.14.2.3 Asia Pacific 93 5.14.2.4 Latin America 94 5.14.2.5 Rest of the World 94 5.15 PORTER’S FIVE FORCES ANALYSIS 95 5.15.1 BARGAINING POWER OF SUPPLIERS 96 5.15.2 BARGAINING POWER OF BUYERS 96 5.15.3 THREAT FROM NEW ENTRANTS 96 5.15.4 THREAT FROM SUBSTITUTES 96 5.15.5 INTENSITY OF COMPETITIVE RIVALRY 96 5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 96 5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 97 5.16.2 BUYING CRITERIA 97 5.17 IMPACT OF AI ON WOUND CARE MARKET 98 5.17.1 INTRODUCTION 98 5.17.2 MARKET POTENTIAL OF AI IN WOUND CARE MARKET 98 5.17.3 IMPACT OF AI ON WOUND CARE MARKET: USE CASES 99 5.17.4 KEY COMPANIES IMPLEMENTING AI 99 5.17.5 FUTURE OF AI IN WOUND CARE MARKET 100 5.18 US 2025 TARIFF 100 5.18.1 INTRODUCTION 100 5.18.2 KEY TARIFF RATES 101 5.18.3 PRICE IMPACT ANALYSIS 101 5.18.4 IMPACT ON COUNTRY/REGION 102 5.18.4.1 North America 102 5.18.4.2 Europe 102 5.18.4.3 Asia Pacific 102 5.18.5 IMPACT ON END-USE INDUSTRIES 103 5.18.5.1 Hospitals and clinics 103 6 WOUND CARE MARKET, BY PRODUCT 104 6.1 INTRODUCTION 105 6.2 ADVANCED WOUND CARE PRODUCTS 105 6.2.1 ADVANCED WOUND DRESSINGS, BY TYPE 108 6.2.1.1 Foam dressings 110 6.2.1.1.1 Silicone dressings 114 6.2.1.1.1.1 Ability of silicone dressings to expedite wound closure and reduce risk of maceration to drive market 114 6.2.1.1.2 Non-silicone dressings 117 6.2.1.1.2.1 Non-silicone dressings are designed for patient comfort and ease of use 117 6.2.1.2 Hydrocolloid dressings 119 6.2.1.2.1 Ability of hydrocolloid dressings to promote granulation and formation of new tissues in open wounds to boost demand 119 6.2.1.3 Film dressings 122 6.2.1.3.1 Film dressings offer strong adhesive properties and adaptability to various wound types 122 6.2.1.4 Alginate dressings 125 6.2.1.4.1 Growing incidence of pressure and diabetic foot ulcers to fuel growth 125 6.2.1.5 Hydrogel dressings 128 6.2.1.5.1 Ability of hydrogel dressings to provide relief and cooling effect on skin to drive market 128 6.2.1.6 Collagen dressings 130 6.2.1.6.1 Favorable reimbursement scenario for collagen dressings to support market 130 6.2.1.7 Hydrofiber dressings 133 6.2.1.7.1 Combination of properties of hydrocolloids and alginates to boost adoption of hydrofiber dressings 133 6.2.1.8 Wound contact layers 136 6.2.1.8.1 Ability of wound contact layers to protect wound beds from bacterial and fungal growth to drive market 136 6.2.1.9 Superabsorbent dressings 138 6.2.1.9.1 Use of superabsorbent dressings for fragile skin to promote growth 138 6.2.1.10 Other advanced wound care dressings 141 6.2.2 ADVANCED WOUND DRESSINGS, BY PROPERTY 145 6.2.2.1 Non-antimicrobial dressings 145 6.2.2.1.1 Need for cost-effective dressing alternatives to drive market 145 6.2.2.2 Antimicrobial dressings 147 6.2.2.2.1 Advanced antimicrobial dressings are designed to prevent or manage infections in wounds 147 6.2.3 DEVICES & ACCESSORIES 149 6.2.3.1 NPWT devices & accessories 152 6.2.3.1.1 Growing adoption of single-use NPWT devices in home care to drive growth 152 6.2.3.2 Debridement devices & accessories 155 6.2.3.2.1 Focus on developing novel technologies to support market 155 6.2.3.3 Wound assessment & monitoring devices 158 6.2.3.3.1 Potential cost-reducing capabilities of wound assessment & monitoring devices to boost adoption 158 6.2.3.4 Other devices & accessories 161 6.2.4 BIOLOGICAL SKIN SUBSTITUTES 164 6.2.4.1 Human donor tissue-derived products 167 6.2.4.1.1 High efficacy of human donor tissue-derived products to support market demand 167 6.2.4.2 Acellular animal-derived products 170 6.2.4.2.1 Recognition of importance of ECM in wound treatment to lead to development of acellular wound care biologics 170 6.2.4.3 Biosynthetic products 172 6.2.4.3.1 Increased bioburden of infected wounds to lead to development of biosynthetic wound care products 172 6.2.5 TOPICAL AGENTS 175 6.2.5.1 Cost-effectiveness and ease of use of topical agents in home care settings to drive demand 175 6.3 SURGICAL WOUND CARE PRODUCTS 178 6.3.1 SUTURES 180 6.3.1.1 High tensile strength of sutures to drive market 180 6.3.2 TISSUE ADHESIVES, SEALANTS, AND GLUES 183 6.3.2.1 Fibrin-based sealants 186 6.3.2.1.1 Fibrin-based sealants replicate final stages of body’s natural blood-clotting process 186 6.3.2.2 Synthetic adhesives 189 6.3.2.2.1 Synthetic adhesives have additional sealing properties than traditional staples 189 6.3.2.3 Collagen-based sealants 191 6.3.2.3.1 Collagen-based sealants are primarily used in surgical procedures to support hemostasis 191 6.3.3 STAPLERS 194 6.3.3.1 Staple lines are consistent and less likely to leak blood or air 194 6.4 TRADITIONAL WOUND CARE PRODUCTS 196 6.4.1 FIXATIONS 199 6.4.1.1 Fixation materials ensure dressings, wound pads, and compresses stay securely in place 199 6.4.2 BANDAGES 201 6.4.2.1 Wide usage of bandages to support market growth 201 6.4.3 GAUZES 204 6.4.3.1 Wide usage of gauzes in surgeries and wound packing to propel market growth 204 6.4.4 FIRST AID PLASTERS 206 6.4.4.1 Need for rapid wound management and protection to propel adoption 206 6.4.5 ABSORBENT PADS 209 6.4.5.1 Wide usage of absorbent pads in wound dressing and exudate management to drive market 209 6.4.6 COMPRESSIONS 212 6.4.6.1 Ability of compression products to reduce swelling to boost demand 212 6.4.7 ISLAND DRESSINGS 214 6.4.7.1 Waterproof, antimicrobial, and absorbent properties of island dressings to drive their demand 214 6.4.8 OTHER TRADITIONAL WOUND CARE PRODUCTS 216 7 WOUND CARE MARKET, BY WOUND TYPE 220 7.1 INTRODUCTION 221 7.2 CHRONIC WOUNDS 221 7.2.1 DIABETIC FOOT ULCERS 224 7.2.1.1 Rising incidence of diabetes to drive market growth 224 7.2.2 PRESSURE ULCERS 228 7.2.2.1 Growing geriatric population to drive market growth 228 7.2.3 VENOUS LEG ULCERS 230 7.2.3.1 Rising prevalence of obesity to drive market growth 230 7.2.4 OTHER CHRONIC WOUNDS 233   7.3 ACUTE WOUNDS 236 7.3.1 SURGICAL & TRAUMATIC WOUNDS 238 7.3.1.1 Rising volume of surgical procedures to drive market 238 7.3.2 BURNS 241 7.3.2.1 High incidence of burn injuries in developing regions to support market growth 241 8 WOUND CARE MARKET, BY END USER 245 8.1 INTRODUCTION 246 8.2 HOSPITALS & CLINICS 246 8.2.1 INPATIENT SETTINGS 250 8.2.1.1 Increasing hospital admissions due to HAIs to drive market 250 8.2.2 OUTPATIENT SETTINGS 253 8.2.2.1 Rising cost of inpatient facilities to spur market for outpatient care settings 253 8.3 HOME CARE SETTINGS 255 8.3.1 DECREASED COSTS AND HIGH CONVENIENCE AND COMFORT OF HOME CARE SETTINGS TO ENSURE MARKET GROWTH 255 8.4 LONG-TERM CARE FACILITIES 258 8.4.1 GROWING GERIATRIC POPULATION TO BOOST NEED FOR BETTER LONG-TERM CARE 258 8.5 OTHER END USERS 260 9 WOUND CARE MARKET, BY REGION 264 9.1 INTRODUCTION 265 9.2 NORTH AMERICA 265 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 266 9.2.2 US 274 9.2.2.1 Rising prevalence of diabetes and supportive reimbursement policies to drive growth 274 9.2.3 CANADA 275 9.2.3.1 Government-backed efforts to support market development 275 9.3 EUROPE 277 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 277 9.3.2 GERMANY 284 9.3.2.1 Rising cases of diabetes and chronic wound burden to boost market 284 9.3.3 FRANCE 285 9.3.3.1 Rising chronic wound cases to drive market expansion 285 9.3.4 UK 286 9.3.4.1 Increase in R&D activity to propel market growth 286 9.3.5 ITALY 288 9.3.5.1 Increased healthcare funding and sustained demand for treatment solutions to drive market 288 9.3.6 SPAIN 289 9.3.6.1 Rising life expectancy and aging population to boost adoption of wound care products 289 9.3.7 RUSSIA 290 9.3.7.1 Government initiatives to raise awareness about diabetes to support market expansion 290 9.3.8 REST OF EUROPE 292 9.4 ASIA PACIFIC 293 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 294 9.4.2 CHINA 302 9.4.2.1 Increasing incidence of diabetic foot ulcers (DFUs) to encourage growth 302 9.4.3 JAPAN 303 9.4.3.1 Evolving healthcare delivery and infrastructure landscape to fuel market 303 9.4.4 INDIA 305 9.4.4.1 Booming medical tourism to speed up growth 305 9.4.5 AUSTRALIA 306 9.4.5.1 Growth of medical manufacturing companies to drive market 306 9.4.6 SOUTH KOREA 308 9.4.6.1 Increasing healthcare spending to sustain growth 308 9.4.7 SINGAPORE 309 9.4.7.1 Increasing focus on wound care therapies to facilitate growth 309 9.4.8 REST OF ASIA PACIFIC 311 9.5 LATIN AMERICA 312 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 313 9.5.2 BRAZIL 320 9.5.2.1 Growth in healthcare sector to drive market 320 9.5.3 MEXICO 321 9.5.3.1 Expanding hospital infrastructure to aid growth 321 9.5.4 REST OF LATIN AMERICA 323 9.6 MIDDLE EAST & AFRICA 324 9.6.1 GROWING DEMAND FOR HEALTHCARE FACILITIES TO DRIVE MARKET 324 9.6.2 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 325 10 COMPETITIVE LANDSCAPE 332 10.1 OVERVIEW 332 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2024 332 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN WOUND CARE MARKET 332 10.3 REVENUE ANALYSIS, 2022–2024 333 10.4 MARKET SHARE ANALYSIS, 2024 334 10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 338 10.5.1 STARS 339 10.5.2 EMERGING LEADERS 339 10.5.3 PERVASIVE PLAYERS 339 10.5.4 PARTICIPANTS 339 10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 341 10.5.5.1 Company footprint 341 10.5.5.2 Region footprint 342 10.5.5.3 Product footprint 343 10.5.5.4 Wound type footprint 344 10.5.5.5 End user footprint 345 10.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024 346 10.6.1 PROGRESSIVE COMPANIES 346 10.6.2 RESPONSIVE COMPANIES 346 10.6.3 DYNAMIC COMPANIES 346 10.6.4 STARTING BLOCKS 346 10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024 348 10.6.5.1 Detailed list of key startups/SMEs 348 10.6.5.2 Competitive benchmarking of key startups/SMEs 349 10.7 COMPANY VALUATION AND FINANCIAL METRICS 349 10.7.1 COMPANY VALUATION 349 10.7.2 FINANCIAL METRICS 350 10.8 BRAND/PRODUCT COMPARISON 351 10.9 COMPETITIVE SCENARIO 352 10.9.1 PRODUCT LAUNCHES & APPROVALS 352 10.9.2 DEALS 353 10.9.3 EXPANSIONS 354 10.9.4 OTHER DEVELOPMENTS 355 11 COMPANY PROFILES 356 11.1 KEY PLAYERS 356 11.1.1 SOLVENTUM 356 11.1.1.1 Business overview 356 11.1.1.2 Products offered 357 11.1.1.3 Recent developments 361 11.1.1.3.1 Product launches & approvals 361 11.1.1.3.2 Other developments 361 11.1.1.4 MnM view 361 11.1.1.4.1 Right to win 361 11.1.1.4.2 Strategic choices 362 11.1.1.4.3 Weaknesses & competitive threats 362 11.1.2 JOHNSON & JOHNSON SERVICES, INC. (ETHICON) 363 11.1.2.1 Business overview 363 11.1.2.2 Products offered 364 11.1.2.3 Recent developments 365 11.1.2.3.1 Product launches & approvals 365 11.1.2.4 MnM view 365 11.1.2.4.1 Right to win 365 11.1.2.4.2 Strategic choices 365 11.1.2.4.3 Weaknesses & competitive threats 366 11.1.3 SMITH+NEPHEW 367 11.1.3.1 Business overview 367 11.1.3.2 Products offered 368 11.1.3.3 Recent developments 371 11.1.3.3.1 Product launches & approvals 371 11.1.3.3.2 Deals 371 11.1.3.3.3 Expansions 372 11.1.3.3.4 Other developments 372 11.1.3.4 MnM view 373 11.1.3.4.1 Right to win 373 11.1.3.4.2 Strategic choices 373 11.1.3.4.3 Weaknesses & competitive threats 373 11.1.4 CARDINAL HEALTH 374 11.1.4.1 Business overview 374 11.1.4.2 Products offered 375 11.1.4.3 Recent developments 379 11.1.4.3.1 Deals 379 11.1.4.3.2 Expansions 379 11.1.4.4 MnM view 380 11.1.4.4.1 Right to win 380 11.1.4.4.2 Strategic choices 380 11.1.4.4.3 Weaknesses & competitive threats 381 11.1.5 MÖLNLYCKE AB 382 11.1.5.1 Business overview 382 11.1.5.2 Products offered 383 11.1.5.3 Recent developments 386 11.1.5.3.1 Deals 386 11.1.5.3.2 Other developments 387 11.1.5.4 MnM view 387 11.1.5.4.1 Right to win 387 11.1.5.4.2 Strategic choices 387 11.1.5.4.3 Weaknesses & competitive threats 387 11.1.6 CONVATEC GROUP PLC 388 11.1.6.1 Business overview 388 11.1.6.2 Products offered 389 11.1.6.3 Recent developments 390 11.1.6.3.1 Product launches & approvals 390 11.1.6.3.2 Deals 391 11.1.7 COLOPLAST GROUP 392 11.1.7.1 Business overview 392 11.1.7.2 Products offered 393 11.1.7.3 Recent developments 395 11.1.7.3.1 Product launches & approvals 395 11.1.7.3.2 Deals 395 11.1.8 ORGANOGENESIS INC. 396 11.1.8.1 Business overview 396 11.1.8.2 Products offered 397 11.1.8.3 Recent developments 397 11.1.8.3.1 Product launches & approvals 397 11.1.8.3.2 Expansions 397 11.1.9 PAUL HARTMANN AG 398 11.1.9.1 Business overview 398 11.1.9.2 Products offered 399 11.1.9.3 Recent developments 402 11.1.9.3.1 Deals 402 11.1.10 MIMEDX GROUP, INC. 403 11.1.10.1 Business overview 403 11.1.10.2 Products offered 404 11.1.10.3 Recent developments 404 11.1.10.3.1 Product launches & approvals 404 11.1.11 OWENS & MINOR 405 11.1.11.1 Business overview 405 11.1.11.2 Products offered 406 11.1.11.3 Recent developments 408 11.1.11.3.1 Deals 408 11.1.11.3.2 Other developments 408 11.1.12 B. BRAUN SE 409 11.1.12.1 Business overview 409 11.1.12.2 Products offered 410 11.1.12.3 Recent developments 412 11.1.12.3.1 Expansions 412 11.1.12.3.2 Other developments 412 11.1.13 ESSITY AKTIEBOLAG 413 11.1.13.1 Business overview 413 11.1.13.2 Products offered 414 11.1.13.3 Recent developments 417 11.1.13.3.1 Other developments 417   11.1.14 INTEGRA LIFESCIENCES CORPORATION 418 11.1.14.1 Business overview 418 11.1.14.2 Products offered 419 11.1.14.3 Recent developments 420 11.1.14.3.1 Product launches & approvals 420 11.1.14.3.2 Other developments 421 11.1.15 AVERY DENNISON CORPORATION 422 11.1.15.1 Business overview 422 11.1.15.2 Products offered 423 11.1.15.3 Recent developments 424 11.1.15.3.1 Expansions 424 11.1.16 MATIV HOLDINGS, INC. 425 11.1.16.1 Business overview 425 11.1.16.2 Products offered 426 11.1.16.3 Recent developments 427 11.1.16.3.1 Deals 427 11.1.17 BIOVENTUS 428 11.1.17.1 Business overview 428 11.1.17.2 Products offered 429 11.1.17.3 Recent developments 430 11.1.17.3.1 Deals 430 11.1.17.3.2 Other developments 430 11.1.18 ZIMMER BIOMET 431 11.1.18.1 Business overview 431 11.1.18.2 Products offered 432 11.1.18.3 Recent developments 433 11.1.18.3.1 Deals 433 11.1.19 MEDTRONIC 434 11.1.19.1 Business overview 434 11.1.19.2 Products offered 436 11.1.20 BAXTER 437 11.1.20.1 Business overview 437 11.1.20.2 Products offered 438 11.1.20.3 Recent developments 439 11.1.20.3.1 Product launches & approvals 439 11.2 OTHER PLAYERS 440 11.2.1 LOHMANN & RAUSCHER GMBH & CO. KG 440 11.2.2 MEDLINE INDUSTRIES, LP 441 11.2.3 DEROYAL INDUSTRIES, INC. 442 11.2.4 WINNER MEDICAL CO., LTD. 443 11.2.5 ADVANCIS (UK) 444 11.2.6 MIL LABORATORIES PVT. LTD. 445 11.2.7 PENSAR MEDICAL 446 11.2.8 HAROMED BV 447 11.2.9 URGO GROUP 448 11.2.10 DIRECT HEALTHCARE GROUP 449 12 APPENDIX 450 12.1 DISCUSSION GUIDE 450 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 453 12.3 CUSTOMIZATION OPTIONS 455 12.4 RELATED REPORTS 455 12.5 AUTHOR DETAILS 456

TABLE 1 WOUND CARE MARKET: INCLUSIONS AND EXCLUSIONS 42 TABLE 2 WOUND CARE MARKET: RISK ASSESSMENT 57 TABLE 3 POPULATION SHARE OF PEOPLE AGED 65 AND ABOVE (% OF TOTAL POPULATION), BY COUNTRY, 2023 66 TABLE 4 ROAD ACCIDENT DEMOGRAPHICS, 2022 67 TABLE 5 CHINA: STATE OF PATIENTS (WITH TYPE 2 DFU) ON DISCHARGE, BY AGE GROUP, JANUARY 2017–DECEMBER 2023 68 TABLE 6 RISKS ASSOCIATED WITH ADVANCED WOUND CARE DEVICES 71 TABLE 7 STRATEGIC DEVELOPMENTS IN ASIA PACIFIC, 2023–2024 72 TABLE 8 AVERAGE SELLING PRICING TREND OF WOUND CARE PRODUCTS, 2023–2025 76 TABLE 9 AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS FOR KEY WOUND TYPES, BY KEY PLAYER, 2023–2025 76 TABLE 10 AVERAGE SELLING PRICE TREND OF WOUND CARE PRODUCTS, BY REGION, 2023–2025 77 TABLE 11 WOUND CARE MARKET: ROLE OF PLAYERS IN ECOSYSTEM 81 TABLE 12 WOUND CARE MARKET: INNOVATIONS AND PATENT REGISTRATIONS, 2023–2025 84 TABLE 13 IMPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 85 TABLE 14 EXPORT DATA FOR HS CODE 300510-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD MILLION) 86 TABLE 15 WOUND CARE MARKET: KEY CONFERENCES AND EVENTS, APRIL 2025–DECEMBER 2026 86 TABLE 16 TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS IN JAPAN 91 TABLE 17 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 92 TABLE 18 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 19 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 93 TABLE 20 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 21 REST OF THE WORLD: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 94 TABLE 22 IMPACT OF PORTER’S FORCES ON WOUND CARE MARKET 95 TABLE 23 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY KEY PRODUCT (%) 97 TABLE 24 KEY BUYING CRITERIA FOR KEY PRODUCTS 98 TABLE 25 RECIPROCAL TARIFF RATES ADJUSTED BY US 101 TABLE 26 WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 105 TABLE 27 ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 105 TABLE 28 ADVANCED WOUND CARE PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 106 TABLE 29 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 106 TABLE 30 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 106 TABLE 31 ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 107 TABLE 32 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 107 TABLE 33 ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 108 TABLE 34 ADVANCED WOUND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 109 TABLE 35 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 109 TABLE 36 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 109 TABLE 37 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 110 TABLE 38 LATIN AMERICA: WOUND CARE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 110 TABLE 39 KEY PRODUCT TYPES IN FOAM DRESSINGS MARKET 111 TABLE 40 FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 112 TABLE 41 FOAM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 112 TABLE 42 NORTH AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 112 TABLE 43 EUROPE: FOAM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 113 TABLE 44 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 113 TABLE 45 LATIN AMERICA: FOAM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 114 TABLE 46 SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 114 TABLE 47 NORTH AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 115 TABLE 48 EUROPE: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 115 TABLE 49 ASIA PACIFIC: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 116 TABLE 50 LATIN AMERICA: SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 116 TABLE 51 NON-SILICONE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 117 TABLE 52 NORTH AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 117 TABLE 53 EUROPE: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 118 TABLE 54 ASIA PACIFIC: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 118 TABLE 55 LATIN AMERICA: NON-SILICONE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 119 TABLE 56 KEY PRODUCT TYPES IN HYDROCOLLOID DRESSINGS MARKET, BY COMPANY 119 TABLE 57 HYDROCOLLOID DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 120 TABLE 58 NORTH AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 120 TABLE 59 EUROPE: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 121 TABLE 60 ASIA PACIFIC: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 121 TABLE 61 LATIN AMERICA: HYDROCOLLOID DRESSINGS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 122 TABLE 62 KEY PRODUCT TYPES IN FILM DRESSINGS MARKET, BY COMPANY 122 TABLE 63 FILM DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 123 TABLE 64 NORTH AMERICA: FILM DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 123 TABLE 65 EUROPE: FILM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 124 TABLE 66 ASIA PACIFIC: FILM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 124 TABLE 67 LATIN AMERICA: FILM DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 125 TABLE 68 KEY PRODUCT TYPES IN ALGINATE DRESSINGS MARKET, BY COMPANY 126 TABLE 69 ALGINATE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 126 TABLE 70 NORTH AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 126 TABLE 71 EUROPE: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 127 TABLE 72 ASIA PACIFIC: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 127 TABLE 73 LATIN AMERICA: ALGINATE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 128 TABLE 74 KEY PRODUCT TYPES IN HYDROGEL DRESSINGS MARKET, BY COMPANY 128 TABLE 75 HYDROGEL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 129 TABLE 76 NORTH AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129 TABLE 77 EUROPE: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 129 TABLE 78 ASIA PACIFIC: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 130 TABLE 79 LATIN AMERICA: HYDROGEL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 130 TABLE 80 KEY PRODUCT TYPES IN COLLAGEN DRESSINGS MARKET, BY COMPANY 131 TABLE 81 COLLAGEN DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 131 TABLE 82 NORTH AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132 TABLE 83 EUROPE: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 132 TABLE 84 ASIA PACIFIC: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 133 TABLE 85 LATIN AMERICA: COLLAGEN DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 133 TABLE 86 KEY PRODUCT TYPES IN HYDROFIBER DRESSINGS MARKET, BY COMPANY 134 TABLE 87 HYDROFIBER DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 134 TABLE 88 NORTH AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134 TABLE 89 EUROPE: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 135 TABLE 90 ASIA PACIFIC: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 135 TABLE 91 LATIN AMERICA: HYDROFIBER DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 136 TABLE 92 KEY PRODUCT TYPES IN WOUND CONTACT LAYERS MARKET, BY COMPANY 136 TABLE 93 WOUND CONTACT LAYERS MARKET, BY REGION, 2023–2030 (USD MILLION) 137 TABLE 94 NORTH AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 137 TABLE 95 EUROPE: WOUND CONTACT LAYERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 137 TABLE 96 ASIA PACIFIC: WOUND CONTACT LAYERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 138 TABLE 97 LATIN AMERICA: WOUND CONTACT LAYERS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 138 TABLE 98 KEY PRODUCT TYPES IN SUPERABSORBENT DRESSINGS MARKET, BY COMPANY 139 TABLE 99 SUPERABSORBENT DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 139 TABLE 100 NORTH AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 140 TABLE 101 EUROPE: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 140 TABLE 102 ASIA PACIFIC: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 141 TABLE 103 LATIN AMERICA: SUPERABSORBENT DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 141 TABLE 104 KEY PRODUCT TYPES IN OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COMPANY 142 TABLE 105 OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 143 TABLE 106 NORTH AMERICA: OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 143 TABLE 107 EUROPE: OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 144 TABLE 108 ASIA PACIFIC: OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 144 TABLE 109 LATIN AMERICA: OTHER ADVANCED WOUND CARE DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 145 TABLE 110 ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 145 TABLE 111 NON-ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 146 TABLE 112 NORTH AMERICA: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 146 TABLE 113 EUROPE: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 146 TABLE 114 ASIA PACIFIC: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 147 TABLE 115 LATIN AMERICA: NON-ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 147 TABLE 116 ANTIMICROBIAL DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 148 TABLE 117 NORTH AMERICA: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 148 TABLE 118 EUROPE: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 148 TABLE 119 ASIA PACIFIC: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 149 TABLE 120 LATIN AMERICA: ANTIMICROBIAL DRESSINGS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 149 TABLE 121 DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 150 TABLE 122 DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 150 TABLE 123 NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 150 TABLE 124 EUROPE: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 151 TABLE 125 ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 151 TABLE 126 LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 152 TABLE 127 KEY PRODUCT TYPES IN NPWT DEVICES & ACCESSORIES MARKET, BY COMPANY 152 TABLE 128 NPWT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 153 TABLE 129 NORTH AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 154 TABLE 130 EUROPE: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 154 TABLE 131 ASIA PACIFIC: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 155 TABLE 132 LATIN AMERICA: NPWT DEVICES & ACCESSORIES MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 155 TABLE 133 KEY PRODUCT TYPES IN DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COMPANY 156 TABLE 134 DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 156 TABLE 135 NORTH AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 157 TABLE 136 EUROPE: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 157 TABLE 137 ASIA PACIFIC: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 158 TABLE 138 LATIN AMERICA: DEBRIDEMENT DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 158 TABLE 139 KEY PRODUCT TYPES IN WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COMPANY 159 TABLE 140 WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 159 TABLE 141 NORTH AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 159 TABLE 142 EUROPE: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 160 TABLE 143 ASIA PACIFIC: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 160 TABLE 144 LATIN AMERICA: WOUND ASSESSMENT & MONITORING DEVICES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 161 TABLE 145 OTHER DEVICES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 162 TABLE 146 NORTH AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 163 TABLE 147 EUROPE: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 163 TABLE 148 ASIA PACIFIC: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 164 TABLE 149 LATIN AMERICA: OTHER DEVICES & ACCESSORIES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 164 TABLE 150 KEY PRODUCT TYPES IN BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COMPANY 165 TABLE 151 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 165 TABLE 152 BIOLOGICAL SKIN SUBSTITUTES MARKET, BY REGION, 2023–2030 (USD MILLION) 166 TABLE 153 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 166 TABLE 154 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 166 TABLE 155 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 167 TABLE 156 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 167 TABLE 157 KEY PRODUCT TYPES IN HUMAN DONOR TISSUE-DERIVED MARKET, BY COMPANY 168 TABLE 158 HUMAN DONOR TISSUE-DERIVED MARKET, BY REGION, 2023–2030 (USD MILLION) 168 TABLE 159 NORTH AMERICA: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 168 TABLE 160 EUROPE: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 169 TABLE 161 ASIA PACIFIC: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 169 TABLE 162 LATIN AMERICA: HUMAN DONOR TISSUE-DERIVED MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 170 TABLE 163 KEY PRODUCT TYPES IN ACELLULAR ANIMAL-DERIVED MARKET, BY COMPANY 170 TABLE 164 ACELLULAR ANIMAL-DERIVED MARKET, BY REGION, 2023–2030 (USD MILLION) 171 TABLE 165 NORTH AMERICA: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 171 TABLE 166 EUROPE: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 171 TABLE 167 ASIA PACIFIC: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 172 TABLE 168 LATIN AMERICA: ACELLULAR ANIMAL-DERIVED MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 172 TABLE 169 KEY PRODUCT TYPES IN BIOSYNTHETIC MARKET, BY COMPANY 173 TABLE 170 BIOSYNTHETIC PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 173 TABLE 171 NORTH AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 173 TABLE 172 EUROPE: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 174 TABLE 173 ASIA PACIFIC: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 174 TABLE 174 LATIN AMERICA: BIOSYNTHETIC PRODUCTS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 175 TABLE 175 KEY PRODUCT TYPES IN TOPICAL AGENTS MARKET, BY COMPANY 176 TABLE 176 TOPICAL AGENTS MARKET, BY REGION, 2023–2030 (USD MILLION) 176 TABLE 177 NORTH AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 177 TABLE 178 EUROPE: TOPICAL AGENTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 177 TABLE 179 ASIA PACIFIC: TOPICAL AGENTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 177 TABLE 180 LATIN AMERICA: TOPICAL AGENTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 178 TABLE 181 SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 178 TABLE 182 SURGICAL WOUND CARE PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 179 TABLE 183 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 179 TABLE 184 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 179 TABLE 185 ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 180 TABLE 186 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 180 TABLE 187 KEY PRODUCT TYPES IN SUTURES MARKET, BY COMPANY 181 TABLE 188 SUTURES MARKET, BY REGION, 2023–2030 (USD MILLION) 181 TABLE 189 NORTH AMERICA: SUTURES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 182 TABLE 190 EUROPE: SUTURES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 182 TABLE 191 ASIA PACIFIC: SUTURES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 182 TABLE 192 LATIN AMERICA: SUTURES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 183 TABLE 193 KEY PRODUCT TYPES IN TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COMPANY 183 TABLE 194 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 184 TABLE 195 TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY REGION, 2023–2030 (USD MILLION) 184 TABLE 196 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 184 TABLE 197 EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 185 TABLE 198 ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 185 TABLE 199 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 186 TABLE 200 FIBRIN-BASED SEALANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 187 TABLE 201 NORTH AMERICA: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 187 TABLE 202 EUROPE: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 187 TABLE 203 ASIA PACIFIC: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 188 TABLE 204 LATIN AMERICA: FIBRIN-BASED SEALANTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 188 TABLE 205 SYNTHETIC ADHESIVES MARKET, BY REGION, 2023–2030 (USD MILLION) 189 TABLE 206 NORTH AMERICA: SYNTHETIC ADHESIVES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 189 TABLE 207 EUROPE: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 190 TABLE 208 ASIA PACIFIC: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 190 TABLE 209 LATIN AMERICA: SYNTHETIC ADHESIVES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 191 TABLE 210 COLLAGEN-BASED SEALANTS MARKET, BY REGION, 2023–2030 (USD MILLION) 191 TABLE 211 NORTH AMERICA: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 192 TABLE 212 EUROPE: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 192 TABLE 213 ASIA PACIFIC: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 193 TABLE 214 LATIN AMERICA: COLLAGEN-BASED SEALANTS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 193 TABLE 215 KEY PRODUCT TYPES IN STAPLERS MARKET, BY COMPANY 194 TABLE 216 STAPLERS MARKET, BY REGION, 2023–2030 (USD MILLION) 194 TABLE 217 NORTH AMERICA: STAPLERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 194 TABLE 218 EUROPE: STAPLERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 195 TABLE 219 ASIA PACIFIC: STAPLERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 195 TABLE 220 LATIN AMERICA: STAPLERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 196 TABLE 221 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 196 TABLE 222 TRADITIONAL WOUND CARE PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 197 TABLE 223 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 197 TABLE 224 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 197 TABLE 225 ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 198 TABLE 226 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 198 TABLE 227 KEY FIXATIONS OFFERED, BY COMPANY 199 TABLE 228 FIXATIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 200 TABLE 229 NORTH AMERICA: FIXATIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 200 TABLE 230 EUROPE: FIXATIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 200 TABLE 231 ASIA PACIFIC: FIXATIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 201 TABLE 232 LATIN AMERICA: FIXATIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 201 TABLE 233 KEY BANDAGES OFFERED, BY COMPANY 202 TABLE 234 BANDAGES MARKET, BY REGION, 2023–2030 (USD MILLION) 202 TABLE 235 NORTH AMERICA: BANDAGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 202 TABLE 236 EUROPE: BANDAGES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 203 TABLE 237 ASIA PACIFIC: BANDAGES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 203 TABLE 238 LATIN AMERICA: BANDAGES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 204 TABLE 239 GAUZES OFFERED, BY COMPANY 204 TABLE 240 GAUZES MARKET, BY REGION, 2023–2030 (USD MILLION) 205 TABLE 241 NORTH AMERICA: GAUZES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 205 TABLE 242 EUROPE: GAUZES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 205 TABLE 243 ASIA PACIFIC: GAUZES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 206 TABLE 244 LATIN AMERICA: GAUZES MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 206 TABLE 245 KEY FIRST AID PLASTER PRODUCTS OFFERED, BY COMPANY 207 TABLE 246 FIRST AID PLASTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 207 TABLE 247 NORTH AMERICA: FIRST AID PLASTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 207 TABLE 248 EUROPE: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 208 TABLE 249 ASIA PACIFIC: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 208 TABLE 250 LATIN AMERICA: FIRST AID PLASTERS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 209 TABLE 251 KEY ABSORBENT PADS OFFERED, BY COMPANY 209 TABLE 252 ABSORBENT PADS MARKET, BY REGION, 2023–2030 (USD MILLION) 210 TABLE 253 NORTH AMERICA: ABSORBENT PADS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 210 TABLE 254 EUROPE: ABSORBENT PADS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 210 TABLE 255 ASIA PACIFIC: ABSORBENT PADS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 211 TABLE 256 LATIN AMERICA: ABSORBENT PADS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 211 TABLE 257 KEY COMPRESSIONS OFFERED, BY COMPANY 212 TABLE 258 COMPRESSIONS MARKET, BY REGION, 2023–2030 (USD MILLION) 212 TABLE 259 NORTH AMERICA: COMPRESSIONS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 213 TABLE 260 EUROPE: COMPRESSIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 213 TABLE 261 ASIA PACIFIC: COMPRESSIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 213 TABLE 262 LATIN AMERICA: COMPRESSIONS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 214 TABLE 263 KEY ISLAND DRESSINGS OFFERED, BY COMPANY 214 TABLE 264 ISLAND DRESSINGS MARKET, BY REGION, 2023–2030 (USD MILLION) 215 TABLE 265 NORTH AMERICA: ISLAND DRESSINGS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 215 TABLE 266 EUROPE: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 215 TABLE 267 ASIA PACIFIC: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 216 TABLE 268 LATIN AMERICA: ISLAND DRESSINGS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 216 TABLE 269 OTHER TRADITIONAL WOUND CARE PRODUCTS OFFERED, BY COMPANY 217 TABLE 270 OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY REGION, 2023–2030 (USD MILLION) 217 TABLE 271 NORTH AMERICA: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 217 TABLE 272 EUROPE: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 218 TABLE 273 ASIA PACIFIC: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 218 TABLE 274 LATIN AMERICA: OTHER TRADITIONAL WOUND CARE PRODUCTS MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 219 TABLE 275 WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 221 TABLE 276 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY TYPE, 2023–2030 (USD MILLION) 222 TABLE 277 WOUND CARE MARKET FOR CHRONIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 222 TABLE 278 NORTH AMERICA: WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 222 TABLE 279 EUROPE: WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 223 TABLE 280 ASIA PACIFIC: WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 223 TABLE 281 LATIN AMERICA: WOUND CARE MARKET FOR CHRONIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 224 TABLE 282 DIABETES-RELATED HEALTHCARE EXPENDITURE, BY TERRITORY, 2024 (USD MILLION) 225 TABLE 283 NUMBER OF ADULT PATIENTS WITH DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (THOUSANDS) 225 TABLE 284 WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY REGION, 2023–2030 (USD MILLION) 226 TABLE 285 NORTH AMERICA: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 226 TABLE 286 EUROPE: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 226 TABLE 287 ASIA PACIFIC: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 227 TABLE 288 LATIN AMERICA: WOUND CARE MARKET FOR DIABETIC FOOT ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 227 TABLE 289 WOUND CARE MARKET FOR PRESSURE ULCERS, BY REGION, 2023–2030 (USD MILLION) 228 TABLE 290 NORTH AMERICA: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 229 TABLE 291 EUROPE: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY/ REGION, 2023–2030 (USD MILLION) 229 TABLE 292 ASIA PACIFIC: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 230 TABLE 293 LATIN AMERICA: WOUND CARE MARKET FOR PRESSURE ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 230 TABLE 294 WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY REGION, 2023–2030 (USD MILLION) 231 TABLE 295 NORTH AMERICA: WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY, 2023–2030 (USD MILLION) 232 TABLE 296 EUROPE: WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 232 TABLE 297 ASIA PACIFIC: WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 233 TABLE 298 LATIN AMERICA: WOUND CARE MARKET FOR VENOUS LEG ULCERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 233 TABLE 299 WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 234 TABLE 300 NORTH AMERICA: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 234 TABLE 301 EUROPE: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 234 TABLE 302 ASIA PACIFIC: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 235 TABLE 303 LATIN AMERICA: WOUND CARE MARKET FOR OTHER CHRONIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 235 TABLE 304 WOUND CARE MARKET FOR ACUTE WOUNDS, BY TYPE, 2023–2030 (USD MILLION) 236 TABLE 305 WOUND CARE MARKET FOR ACUTE WOUNDS, BY REGION, 2023–2030 (USD MILLION) 236 TABLE 306 NORTH AMERICA: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 237 TABLE 307 EUROPE: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 237 TABLE 308 ASIA PACIFIC: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 238 TABLE 309 LATIN AMERICA: WOUND CARE MARKET FOR ACUTE WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 238 TABLE 310 WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY REGION, 2023–2030 (USD MILLION) 240 TABLE 311 NORTH AMERICA: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY, 2023–2030 (USD MILLION) 240 TABLE 312 EUROPE: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 240 TABLE 313 ASIA PACIFIC: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 241 TABLE 314 LATIN AMERICA: WOUND CARE MARKET FOR SURGICAL & TRAUMATIC WOUNDS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 241 TABLE 315 WOUND CARE MARKET FOR BURNS, BY REGION, 2023–2030 (USD MILLION) 242 TABLE 316 NORTH AMERICA: WOUND CARE MARKET FOR BURNS, BY COUNTRY, 2023–2030 (USD MILLION) 243 TABLE 317 EUROPE: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 243 TABLE 318 ASIA PACIFIC: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 244 TABLE 319 LATIN AMERICA: WOUND CARE MARKET FOR BURNS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 244 TABLE 320 WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 246 TABLE 321 HOSPITALS PER CAPITA, BY COUNTRY, 2024 247 TABLE 322 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY TYPE, 2023–2030 (USD MILLION) 248 TABLE 323 WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2023–2030 (USD MILLION) 248 TABLE 324 NORTH AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2023–2030 (USD MILLION) 248 TABLE 325 EUROPE: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 249 TABLE 326 ASIA PACIFIC: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 249 TABLE 327 LATIN AMERICA: WOUND CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 250 TABLE 328 WOUND CARE MARKET FOR INPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 250 TABLE 329 NORTH AMERICA: WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 251 TABLE 330 EUROPE: WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 251 TABLE 331 ASIA PACIFIC: WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 252 TABLE 332 LATIN AMERICA: WOUND CARE MARKET FOR INPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 252 TABLE 333 WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY REGION, 2023–2030 (USD MILLION) 253 TABLE 334 NORTH AMERICA: WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 253 TABLE 335 EUROPE: WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 254 TABLE 336 ASIA PACIFIC: WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 254 TABLE 337 LATIN AMERICA: WOUND CARE MARKET FOR OUTPATIENT SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 255 TABLE 338 WOUND CARE MARKET FOR HOME CARE SETTINGS, BY REGION, 2023–2030 (USD MILLION) 256 TABLE 339 NORTH AMERICA: WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2023–2030 (USD MILLION) 256 TABLE 340 EUROPE: WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 257 TABLE 341 ASIA PACIFIC: WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 257 TABLE 342 LATIN AMERICA: WOUND CARE MARKET FOR HOME CARE SETTINGS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 258 TABLE 343 WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY REGION, 2023–2030 (USD MILLION) 259 TABLE 344 NORTH AMERICA: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY, 2023–2030 (USD MILLION) 259 TABLE 345 EUROPE: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 259 TABLE 346 ASIA PACIFIC: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 260 TABLE 347 LATIN AMERICA: WOUND CARE MARKET FOR LONG-TERM CARE FACILITIES, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 260 TABLE 348 WOUND CARE MARKET FOR OTHER END USERS, BY REGION, 2023–2030 (USD MILLION) 261 TABLE 349 NORTH AMERICA: WOUND CARE MARKET FOR OTHER END USERS, 2023–2030 (USD MILLION) 261 TABLE 350 EUROPE: WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 262 TABLE 351 ASIA PACIFIC: WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 262 TABLE 352 LATIN AMERICA: WOUND CARE MARKET FOR OTHER END USERS, BY COUNTRY/REGION, 2022–2030 (USD MILLION) 263 TABLE 353 WOUND CARE MARKET, BY REGION, 2023–2030 (USD MILLION) 265 TABLE 354 NORTH AMERICA: MACROECONOMIC INDICATORS 266 TABLE 355 NORTH AMERICA: WOUND CARE MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 267 TABLE 356 NORTH AMERICA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 268 TABLE 357 NORTH AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 268 TABLE 358 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 359 NORTH AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 269 TABLE 360 NORTH AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 270 TABLE 361 NORTH AMERICA: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 362 NORTH AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 270 TABLE 363 NORTH AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 364 NORTH AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 271 TABLE 365 NORTH AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 366 NORTH AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 272 TABLE 367 NORTH AMERICA: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 272 TABLE 368 NORTH AMERICA: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 369 NORTH AMERICA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 273 TABLE 370 NORTH AMERICA: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 273 TABLE 371 US: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 274 TABLE 372 US: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 274 TABLE 373 US: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 275 TABLE 374 ESTIMATED NUMBER OF DIABETICS IN CANADA, 2024 VS. 2034 275 TABLE 375 CANADA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 276 TABLE 376 CANADA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 276 TABLE 377 CANADA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 276 TABLE 378 EUROPE: MACROECONOMIC INDICATORS 277 TABLE 379 EUROPE: WOUND CARE MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 278 TABLE 380 EUROPE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 278 TABLE 381 EUROPE: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 382 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 279 TABLE 383 EUROPE: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 384 EUROPE: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 280 TABLE 385 EUROPE: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 280 TABLE 386 EUROPE: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 387 EUROPE: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 388 EUROPE: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 281 TABLE 389 EUROPE: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 390 EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 282 TABLE 391 EUROPE: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 282 TABLE 392 EUROPE: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 393 EUROPE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 283 TABLE 394 EUROPE: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 283 TABLE 395 GERMANY: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 284 TABLE 396 GERMANY: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 284 TABLE 397 GERMANY: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 285 TABLE 398 FRANCE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 285 TABLE 399 FRANCE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 286 TABLE 400 FRANCE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 286 TABLE 401 UK: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 287 TABLE 402 UK: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 287 TABLE 403 UK: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 287 TABLE 404 ITALY: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 288 TABLE 405 ITALY: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 288 TABLE 406 ITALY: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 289 TABLE 407 SPAIN: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 289 TABLE 408 SPAIN: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 290 TABLE 409 SPAIN: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 290 TABLE 410 RUSSIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 291 TABLE 411 RUSSIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 291 TABLE 412 RUSSIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 291 TABLE 413 REST OF EUROPE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 292 TABLE 414 REST OF EUROPE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 293 TABLE 415 REST OF EUROPE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 293 TABLE 416 ASIA PACIFIC: KEY MACROECONOMIC INDICATORS 294 TABLE 417 ASIA PACIFIC: WOUND CARE MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 296 TABLE 418 ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 296 TABLE 419 ASIA PACIFIC: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 296 TABLE 420 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 421 ASIA PACIFIC: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 297 TABLE 422 ASIA PACIFIC: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 298 TABLE 423 ASIA PACIFIC: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 424 ASIA PACIFIC: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 298 TABLE 425 ASIA PACIFIC: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 426 ASIA PACIFIC: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 299 TABLE 427 ASIA PACIFIC: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 428 ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 300 TABLE 429 ASIA PACIFIC: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 300 TABLE 430 ASIA PACIFIC: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 431 ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 301 TABLE 432 ASIA PACIFIC: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 301 TABLE 433 CHINA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 302 TABLE 434 CHINA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 302 TABLE 435 CHINA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 303 TABLE 436 JAPAN: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 304 TABLE 437 JAPAN: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 304 TABLE 438 JAPAN: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 304 TABLE 439 INDIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 305 TABLE 440 INDIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 306 TABLE 441 INDIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 306 TABLE 442 AUSTRALIA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 307 TABLE 443 AUSTRALIA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 307 TABLE 444 AUSTRALIA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 307 TABLE 445 SOUTH KOREA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 308 TABLE 446 SOUTH KOREA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 308 TABLE 447 SOUTH KOREA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 309 TABLE 448 SINGAPORE: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 310 TABLE 449 SINGAPORE: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 310 TABLE 450 SINGAPORE: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 310 TABLE 451 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 311 TABLE 452 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 312 TABLE 453 REST OF ASIA PACIFIC: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 312 TABLE 454 LATIN AMERICA: KEY MACROECONOMIC INDICATORS 313 TABLE 455 LATIN AMERICA: WOUND CARE MARKET, BY COUNTRY/REGION, 2023–2030 (USD MILLION) 313 TABLE 456 LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 314 TABLE 457 LATIN AMERICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 314 TABLE 458 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 459 LATIN AMERICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 315 TABLE 460 LATIN AMERICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 316 TABLE 461 LATIN AMERICA: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 462 LATIN AMERICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 316 TABLE 463 LATIN AMERICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 464 LATIN AMERICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 317 TABLE 465 LATIN AMERICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 466 LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 318 TABLE 467 LATIN AMERICA: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 318 TABLE 468 LATIN AMERICA: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 469 LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 319 TABLE 470 LATIN AMERICA: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 319 TABLE 471 BRAZIL: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 320 TABLE 472 BRAZIL: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 321 TABLE 473 BRAZIL: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 321 TABLE 474 MEXICO: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 322 TABLE 475 MEXICO: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 322 TABLE 476 MEXICO: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 322 TABLE 477 REST OF LATIN AMERICA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 323 TABLE 478 REST OF LATIN AMERICA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 323 TABLE 479 REST OF LATIN AMERICA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 324 TABLE 480 MIDDLE EAST & AFRICA: KEY MACROECONOMIC INDICATORS 325 TABLE 481 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 325 TABLE 482 MIDDLE EAST & AFRICA: ADVANCED WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 483 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 326 TABLE 484 MIDDLE EAST & AFRICA: FOAM DRESSINGS MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 485 MIDDLE EAST & AFRICA: ADVANCED WOUND DRESSINGS MARKET, BY PROPERTY, 2023–2030 (USD MILLION) 327 TABLE 486 MIDDLE EAST & AFRICA: DEVICES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 327 TABLE 487 MIDDLE EAST & AFRICA: BIOLOGICAL SKIN SUBSTITUTES MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 488 MIDDLE EAST & AFRICA: SURGICAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 489 MIDDLE EAST & AFRICA: TISSUE ADHESIVES, SEALANTS, AND GLUES MARKET, BY TYPE, 2023–2030 (USD MILLION) 328 TABLE 490 MIDDLE EAST & AFRICA: TRADITIONAL WOUND CARE PRODUCTS MARKET, BY TYPE, 2023–2030 (USD MILLION) 329 TABLE 491 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY WOUND TYPE, 2023–2030 (USD MILLION) 329 TABLE 492 MIDDLE EAST & AFRICA: CHRONIC WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 493 MIDDLE EAST & AFRICA: ACUTE WOUND MARKET, BY TYPE, 2023–2030 (USD MILLION) 330 TABLE 494 MIDDLE EAST & AFRICA: WOUND CARE MARKET, BY END USER, 2023–2030 (USD MILLION) 330 TABLE 495 MIDDLE EAST & AFRICA: HOSPITALS & CLINICS MARKET, BY TYPE, 2023–2030 (USD MILLION) 331 TABLE 496 OVERVIEW OF STRATEGIES DEPLOYED BY KEY PLAYERS, JANUARY 2022–MAY 2025 332 TABLE 497 WOUND CARE MARKET: DEGREE OF COMPETITION 335 TABLE 498 WOUND CARE MARKET: REGION FOOTPRINT 342 TABLE 499 WOUND CARE MARKET: PRODUCT FOOTPRINT 343 TABLE 500 WOUND CARE MARKET: WOUND TYPE FOOTPRINT 344 TABLE 501 WOUND CARE MARKET: END USER FOOTPRINT 345 TABLE 502 WOUND CARE MARKET: DETAILED LIST OF KEY STARTUPS/SMES 348 TABLE 503 WOUND CARE MARKET: COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES 349 TABLE 504 WOUND CARE MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 352 TABLE 505 WOUND CARE MARKET: DEALS, JANUARY 2022–MAY 2025 353 TABLE 506 WOUND CARE MARKET: EXPANSIONS, JANUARY 2022–MAY 2025 354 TABLE 507 WOUND CARE MARKET: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 355 TABLE 508 SOLVENTUM: COMPANY OVERVIEW 356 TABLE 509 SOLVENTUM: PRODUCTS OFFERED 357 TABLE 510 SOLVENTUM: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 361 TABLE 511 SOLVENTUM: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 361 TABLE 512 JOHNSON & JOHNSON SERVICES, INC.: COMPANY OVERVIEW 363 TABLE 513 JOHNSON & JOHNSON SERVICES, INC.: PRODUCTS OFFERED 364 TABLE 514 JOHNSON & JOHNSON SERVICES, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 365 TABLE 515 SMITH+NEPHEW: COMPANY OVERVIEW 367 TABLE 516 SMITH+NEPHEW: PRODUCTS OFFERED 368 TABLE 517 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 371 TABLE 518 SMITH+NEPHEW: DEALS, JANUARY 2022–MAY 2025 371 TABLE 519 SMITH+NEPHEW: EXPANSIONS, JANUARY 2022–MAY 2025 372 TABLE 520 SMITH+NEPHEW: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 372 TABLE 521 CARDINAL HEALTH: COMPANY OVERVIEW 374 TABLE 522 CARDINAL HEALTH: PRODUCTS OFFERED 375 TABLE 523 CARDINAL HEALTH: DEALS, JANUARY 2022–MAY 2025 379 TABLE 524 CARDINAL HEALTH: EXPANSIONS, JANUARY 2022–MAY 2025 379 TABLE 525 MÖLNLYCKE AB: COMPANY OVERVIEW 382 TABLE 526 MÖLNLYCKE AB: PRODUCTS OFFERED 383 TABLE 527 MÖLNLYCKE AB: DEALS, JANUARY 2022–MAY 2025 386 TABLE 528 MÖLNLYCKE AB: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 387 TABLE 529 CONVATEC GROUP PLC: COMPANY OVERVIEW 388 TABLE 530 CONVATEC GROUP PLC: PRODUCTS OFFERED 389 TABLE 531 CONVATEC GROUP PLC: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 390 TABLE 532 CONVATEC GROUP PLC: DEALS, JANUARY 2022–MAY 2025 391 TABLE 533 COLOPLAST GROUP: COMPANY OVERVIEW 392 TABLE 534 COLOPLAST GROUP: PRODUCTS OFFERED 393 TABLE 535 COLOPLAST GROUP: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 395 TABLE 536 COLOPLAST GROUP: DEALS, JANUARY 2022–MAY 2025 395 TABLE 537 ORGANOGENESIS INC.: COMPANY OVERVIEW 396 TABLE 538 ORGANOGENESIS INC.: PRODUCTS OFFERED 397 TABLE 539 ORGANOGENESIS INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 397 TABLE 540 ORGANOGENESIS INC.: EXPANSIONS, JANUARY 2022–MAY 2025 397 TABLE 541 PAUL HARTMANN AG: COMPANY OVERVIEW 398 TABLE 542 PAUL HARTMANN AG: PRODUCTS OFFERED 399 TABLE 543 PAUL HARTMANN AG: DEALS, JANUARY 2022–MAY 2025 402 TABLE 544 MIMEDX GROUP, INC.: COMPANY OVERVIEW 403 TABLE 545 MIMEDX GROUP, INC.: PRODUCTS OFFERED 404 TABLE 546 MIMEDX GROUP, INC.: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 404 TABLE 547 OWENS & MINOR: COMPANY OVERVIEW 405 TABLE 548 OWENS & MINOR: PRODUCTS OFFERED 406 TABLE 549 OWENS & MINOR: DEALS, JANUARY 2022–JANUARY 2025 408 TABLE 550 OWENS & MINOR: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 408 TABLE 551 B. BRAUN SE: COMPANY OVERVIEW 409 TABLE 552 B. BRAUN SE: PRODUCTS OFFERED 410 TABLE 553 B. BRAUN SE: EXPANSIONS, JANUARY 2022–MAY 2025 412 TABLE 554 B. BRAUN SE: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 412 TABLE 555 ESSITY AKTIEBOLAG: COMPANY OVERVIEW 413 TABLE 556 ESSITY AKTIEBOLAG: PRODUCTS OFFERED 414 TABLE 557 ESSITY AKTLEBOLAG: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 417 TABLE 558 INTEGRA LIFESCIENCES CORPORATION: COMPANY OVERVIEW 418 TABLE 559 INTEGRA LIFESCIENCES CORPORATION: PRODUCTS OFFERED 419 TABLE 560 INTEGRA LIFESCIENCES CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 420 TABLE 561 INTEGRA LIFESCIENCES CORPORATION: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 421 TABLE 562 AVERY DENNISON CORPORATION: COMPANY OVERVIEW 422 TABLE 563 AVERY DENNISON CORPORATION: PRODUCTS OFFERED 423 TABLE 564 AVERY DENNISON CORPORATION: EXPANSIONS, JANUARY 2022–MAY 2025 424 TABLE 565 MATIV HOLDINGS, INC.: COMPANY OVERVIEW 425 TABLE 566 MATIV HOLDINGS, INC.: PRODUCTS OFFERED 426 TABLE 567 MATIV HOLDINGS, INC.: DEALS, JANUARY 2022–MAY 2025 427 TABLE 568 BIOVENTUS: COMPANY OVERVIEW 428 TABLE 569 BIOVENTUS: PRODUCTS OFFERED 429 TABLE 570 BIOVENTUS: DEALS, JANUARY 2022–JANUARY 2025 430 TABLE 571 BIOVENTUS: OTHER DEVELOPMENTS, JANUARY 2022–MAY 2025 430 TABLE 572 ZIMMER BIOMET: COMPANY OVERVIEW 431 TABLE 573 ZIMMER BIOMET: PRODUCTS OFFERED 432 TABLE 574 ZIMMER BIOMET: DEALS, JANUARY 2022–MAY 2025 433 TABLE 575 MEDTRONIC: COMPANY OVERVIEW 434 TABLE 576 MEDTRONIC: PRODUCTS OFFERED 436 TABLE 577 BAXTER: COMPANY OVERVIEW 437 TABLE 578 BAXTER: PRODUCTS OFFERED 438 TABLE 579 BAXTER: PRODUCT LAUNCHES & APPROVALS, JANUARY 2022–MAY 2025 439 TABLE 580 LOHMANN & RAUSCHER GMBH & CO. KG: COMPANY OVERVIEW 440 TABLE 581 MEDLINE INDUSTRIES, LP: COMPANY OVERVIEW 441 TABLE 582 DEROYAL INDUSTRIES, INC.: COMPANY OVERVIEW 442 TABLE 583 WINNER MEDICAL CO., LTD.: COMPANY OVERVIEW 443 TABLE 584 ADVANCIS (UK): COMPANY OVERVIEW 444 TABLE 585 MIL LABORATORIES PVT. LTD.: COMPANY OVERVIEW 445 TABLE 586 PENSAR MEDICAL: COMPANY OVERVIEW 446 TABLE 587 HAROMED BV: COMPANY OVERVIEW 447 TABLE 588 URGO GROUP: COMPANY OVERVIEW 448 TABLE 589 DIRECT HEALTHCARE GROUP: COMPANY OVERVIEW 449 FIGURE 1 MARKET SEGMENTATION AND REGIONAL SCOPE 41 FIGURE 2 WOUND CARE MARKET: RESEARCH DESIGN 46 FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 51 FIGURE 4 BOTTOM-UP APPROACH: COMPANY REVENUE ESTIMATION APPROACH 52 FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 53 FIGURE 6 WOUND CARE MARKET: TOP-DOWN APPROACH 53 FIGURE 7 DATA TRIANGULATION METHODOLOGY 55 FIGURE 8 WOUND CARE MARKET, BY PRODUCT, 2025 VS. 2030 (USD MILLION) 58 FIGURE 9 WOUND CARE MARKET, BY WOUND TYPE, 2025 VS. 2030 (USD MILLION) 59 FIGURE 10 WOUND CARE MARKET, BY END USER, 2025 VS. 2030 (USD MILLION) 59 FIGURE 11 GEOGRAPHICAL SNAPSHOT OF WOUND CARE MARKET 60 FIGURE 12 INCREASING PREVALENCE OF DIABETES TO DRIVE MARKET GROWTH 62 FIGURE 13 HOSPITALS & CLINICS SEGMENT AND CHINA ACCOUNTED FOR SIGNIFICANT SHARE IN 2024 63 FIGURE 14 JAPAN TO RECORD HIGHEST GROWTH RATE FROM 2025 TO 2030 64 FIGURE 15 ASIA PACIFIC TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 64 FIGURE 16 WOUND CARE MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65 FIGURE 17 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 75 FIGURE 18 VALUE CHAIN ANALYSIS 78 FIGURE 19 SUPPLY CHAIN ANALYSIS 79 FIGURE 20 ECOSYSTEM ANALYSIS 80 FIGURE 21 INVESTMENT AND FUNDING SCENARIO, 2020–2025 (USD MILLION) 81 FIGURE 22 WOUND CARE MARKET: PATENT ANALYSIS, JANUARY 2015–DECEMBER 2024 83 FIGURE 23 PORTER’S FIVE FORCES ANALYSIS 95 FIGURE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY KEY PRODUCT 97 FIGURE 25 KEY BUYING CRITERIA FOR KEY PRODUCTS 97 FIGURE 26 IMPACT OF AI ON WOUND CARE MARKET: USE CASES 99 FIGURE 27 NORTH AMERICA: WOUND CARE MARKET SNAPSHOT 267 FIGURE 28 ASIA PACIFIC: WOUND CARE MARKET SNAPSHOT 295 FIGURE 29 REVENUE ANALYSIS OF KEY PLAYERS, 2022–2024 (USD MILLION) 334 FIGURE 30 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 335 FIGURE 31 ADVANCED WOUND CARE PRODUCTS: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 336 FIGURE 32 NEGATIVE PRESSURE WOUND THERAPY (NPWT): MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 337 FIGURE 33 ADVANCED WOUND DRESSINGS: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 337 FIGURE 34 TRADITIONAL WOUND CARE PRODUCTS: MARKET SHARE ANALYSIS OF KEY PLAYERS, 2024 338 FIGURE 35 RANKING OF KEY PLAYERS, 2024 338 FIGURE 36 WOUND CARE MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 340 FIGURE 37 WOUND CARE MARKET: COMPANY FOOTPRINT 341 FIGURE 38 WOUND CARE MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2024 347 FIGURE 39 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN, AND 5-YEAR STOCK BETA OF KEY VENDORS 349 FIGURE 40 EV/EBITDA OF KEY VENDORS 350 FIGURE 41 BRAND/PRODUCT COMPARATIVE ANALYSIS 351 FIGURE 42 SOLVENTUM: COMPANY SNAPSHOT (2024) 357 FIGURE 43 JOHNSON & JOHNSON SERVICES, INC.: COMPANY SNAPSHOT (2024) 364 FIGURE 44 SMITH+NEPHEW: COMPANY SNAPSHOT (2024) 368 FIGURE 45 CARDINAL HEALTH: COMPANY SNAPSHOT (2024) 375 FIGURE 46 MÖLNLYCKE AB: COMPANY SNAPSHOT (2024) 383 FIGURE 47 CONVATEC GROUP PLC: COMPANY SNAPSHOT (2024) 389 FIGURE 48 COLOPLAST GROUP: COMPANY SNAPSHOT (2024) 393 FIGURE 49 ORGANOGENESIS INC.: COMPANY SNAPSHOT (2024) 396 FIGURE 50 PAUL HARTMANN AG: COMPANY SNAPSHOT (2024) 399 FIGURE 51 MIMEDX GROUP, INC.: COMPANY SNAPSHOT (2024) 403 FIGURE 52 OWENS & MINOR: COMPANY SNAPSHOT (2024) 406 FIGURE 53 B. BRAUN SE: COMPANY SNAPSHOT (2024) 410 FIGURE 54 ESSITY AKTIEBOLAG: COMPANY SNAPSHOT (2024) 414 FIGURE 55 INTEGRA LIFESCIENCES CORPORATION: COMPANY SNAPSHOT (2024) 419 FIGURE 56 AVERY DENNISON CORPORATION: COMPANY SNAPSHOT (2024) 423 FIGURE 57 MATIV HOLDINGS, INC.: COMPANY SNAPSHOT (2024) 426 FIGURE 58 BIOVENTUS: COMPANY SNAPSHOT (2024) 429 FIGURE 59 ZIMMER BIOMET: COMPANY SNAPSHOT (2024) 432 FIGURE 60 MEDTRONIC: COMPANY SNAPSHOT (2024) 435 FIGURE 61 BAXTER: COMPANY SNAPSHOT (2024) 438